Evommune, Inc. (EVMN)

Data as of Jul 10, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch EVMN

See up to 3 months of EVMN. The 7-day demo opens the 1M and 3M ranges and puts EVMN on your watchlist.

Latest EVMN insider trades

Kyle Carver - Officer
Open-market purchase$13K
Jul 8, 2026
Arthur S. Kirsch
Open-market purchase$133K

About Evommune, Inc. (EVMN)

Evommune, Inc. is an SEC registrant, filing under CIK 0002044725, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector. Its offering priced on 6 November 2025 and it trades on NASDAQ.

Sector: Health Care

SEC filings for EVMN on EDGAR

EVMN Form 4 activity by transaction type, last 90 days

No Form 4 activity for EVMN in the last 90 days.

EVMN insider transactions (Form 4)

42 Form 4 filings on record, the earliest from Nov 7, 2025, newest first. Filing history page 2 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Nov 7, 2025	Luis C. Pena - Officer	Other	Common Stock	24,225	-^{footnote F1}	-
Nov 7, 2025	Luis C. Pena - Officer	Other	Series Seed Preferred Stock	206,355	-^{footnote F1}	-
Footnote F1 (price): Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.
Nov 7, 2025	Robert Lorne Hopfner	Other	Common Stock	3,026	-^{footnote F1}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Common Stock	1,441,032	-^{footnote F1,F3,F4,F5}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Common Stock	1,632,441	-^{footnote F1,F3,F4,F5}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Common Stock	294,502	-^{footnote F5}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series Seed Preferred Stock	25,790	-^{footnote F1}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series Seed Preferred Stock	7,145,647	-^{footnote F1}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series Seed Preferred Stock	3,572,816	-^{footnote F1}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series A Preferred Stock	2,582,243	-^{footnote F3}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series A Preferred Stock	7,230,283	-^{footnote F3}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series B Preferred Stock	1,895,260	-^{footnote F4}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series B Preferred Stock	2,104,740	-^{footnote F4}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series C Preferred Stock	313,571	-^{footnote F5}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series C Preferred Stock	313,571	-^{footnote F5}	-
Nov 7, 2025	Robert Lorne Hopfner	Other	Series C Preferred Stock	2,508,575	-^{footnote F5}	-
Footnote F1 (price): Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-8.518 basis and had no expiration date. Footnote F3 (price): Each share of Series A Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.9557 basis and had no expiration date. Footnote F4 (price): Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date. Footnote F5 (price): Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-8.518 basis and had no expiration date.
Nov 7, 2025	David E. Cohen	Other	Common Stock	6,056	-^{footnote F1}	-
Nov 7, 2025	David E. Cohen	Other	Series Seed Preferred Stock	51,588	-^{footnote F1}	-
Footnote F1 (price): Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.
Nov 7, 2025	RA CAPITAL MANAGEMENT, L.P.	Other	Common Stock	1,517,329	-^{footnote F1}	-
Nov 7, 2025	RA CAPITAL MANAGEMENT, L.P.	Other	Common Stock	691,441	-^{footnote F1}	-
Nov 7, 2025	RA CAPITAL MANAGEMENT, L.P.	Open-market purchase	Common Stock	1,157,096	$16.00	$18.51M
Nov 7, 2025	RA CAPITAL MANAGEMENT, L.P.	Open-market purchase	Common Stock	92,904	$16.00	$1.49M
Nov 7, 2025	RA CAPITAL MANAGEMENT, L.P.	Other	Series C Preferred Stock	12,924,620	-^{footnote F1}	-
Nov 7, 2025	RA CAPITAL MANAGEMENT, L.P.	Other	Series C Preferred Stock	5,889,699	-^{footnote F1}	-
Footnote F1 (price): Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.
Nov 5, 2025	Jeegar Pravinkumar Patel - Officer	Grant or award	Employee Stock Option (Right to Buy)	179,619	$0.00	-
Nov 5, 2025	Janice Suzann Drew - Officer	Grant or award	Employee Stock Option (Right to Buy)	231,274	$0.00	-
Nov 5, 2025	Kyle Carver - Officer	Grant or award	Employee Stock Option (Right to Buy)	279,408	$0.00	-
Nov 5, 2025	Gregory S. Moss - Officer	Grant or award	Employee Stock Option (Right to Buy)	293,496	$0.00	-
Nov 5, 2025	Luis C. Pena - Officer	Grant or award	Employee Stock Option (Right to Buy)	796,841	$0.00	-
Nov 5, 2025	David E. Cohen	Grant or award	Stock Option (Right to Buy)	37,960	$0.00	-
Nov 5, 2025	Arthur S. Kirsch	Grant or award	Stock Option (Right to Buy)	37,960	$0.00	-
Nov 5, 2025	Benjamin F. McGraw III	Grant or award	Stock Option (Right to Buy)	37,960	$0.00	-

Recent EVMN Form 8-K filings

Read EVMN company news

Oct 1, 2026Item 7.01, 9.01

Read the filing on SEC EDGAR

Sep 23, 2026Item 7.01, 9.01

Read the filing on SEC EDGAR

Sep 15, 2026Item 7.01, 9.01

Read the filing on SEC EDGAR

Sep 8, 2026Item 7.01, 8.01, 9.01

Recent EVMN Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Jun 22, 2026	-	-	-	-	View on EDGAR
Jun 2, 2026	-	-	-	-

EVMN insider trading FAQ

What is the latest insider trade for EVMN?

Evommune, Inc. (EVMN) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-10. The full record for EVMN runs to 42 Form 4 filings, the earliest from 2025-11-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying EVMN stock?

No insider purchases of EVMN were filed in the last 90 days. 7 purchases are on record for this company.

How many insiders are selling EVMN stock?

No insider sales of EVMN were filed in the last 90 days. 9 sales are on record for this company.

Where can I see EVMN SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects EVMN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Jul 10, 2026 - Kyle Carver view on EDGAR
Jul 9, 2026 - Arthur S. Kirsch view on EDGAR
Jun 25, 2026 - Janice Suzann Drew view on EDGAR
Jun 25, 2026 - Jeegar Pravinkumar Patel view on EDGAR
Jun 24, 2026 - Luis C. Pena view on EDGAR
Jun 4, 2026 - Benjamin F. McGraw III view on EDGAR
Jun 4, 2026 - Arthur S. Kirsch view on EDGAR
Jun 4, 2026 - David E. Cohen view on EDGAR
Jun 4, 2026 - Jeegar Pravinkumar Patel view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where EVMN's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow EVMN with a 7-day demo

EVMN on your watchlist
Every EVMN Form 4 filing on record
Up to 3 months of EVMN price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Date

Insider

Transaction

Security

Price

Value

Nov 7, 2025

Luis C. Pena - Officer

Other

Common Stock

24,225

-^{footnote F1}

Nov 7, 2025

Luis C. Pena - Officer

Other

Series Seed Preferred Stock

206,355

-^{footnote F1}

Footnote F1 (price): Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.

Nov 7, 2025

Robert Lorne Hopfner

Other

Common Stock

3,026

-^{footnote F1}

Nov 7, 2025

Robert Lorne Hopfner

Other

Common Stock

1,441,032

-^{footnote F1,F3,F4,F5}

Nov 7, 2025

Robert Lorne Hopfner

Other

Common Stock

1,632,441

-^{footnote F1,F3,F4,F5}

Nov 7, 2025

Robert Lorne Hopfner

Other

Common Stock

294,502

-^{footnote F5}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series Seed Preferred Stock

25,790

-^{footnote F1}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series Seed Preferred Stock

7,145,647

-^{footnote F1}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series Seed Preferred Stock

3,572,816

-^{footnote F1}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series A Preferred Stock

2,582,243

-^{footnote F3}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series A Preferred Stock

7,230,283

-^{footnote F3}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series B Preferred Stock

1,895,260

-^{footnote F4}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series B Preferred Stock

2,104,740

-^{footnote F4}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series C Preferred Stock

313,571

-^{footnote F5}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series C Preferred Stock

313,571

-^{footnote F5}

Nov 7, 2025

Robert Lorne Hopfner

Other

Series C Preferred Stock

2,508,575

-^{footnote F5}

Footnote F1 (price): Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-8.518 basis and had no expiration date.
Footnote F3 (price): Each share of Series A Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.9557 basis and had no expiration date.
Footnote F4 (price): Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date.
Footnote F5 (price): Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-8.518 basis and had no expiration date.

Nov 7, 2025

David E. Cohen

Other

Common Stock

6,056

-^{footnote F1}

Nov 7, 2025

David E. Cohen

Other

Series Seed Preferred Stock

51,588

-^{footnote F1}

Footnote F1 (price): Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.

Nov 7, 2025

RA CAPITAL MANAGEMENT, L.P.

Other

Common Stock

1,517,329

-^{footnote F1}

Nov 7, 2025

RA CAPITAL MANAGEMENT, L.P.

Other

Common Stock

691,441

-^{footnote F1}

Nov 7, 2025

RA CAPITAL MANAGEMENT, L.P.

Open-market purchase

Common Stock

1,157,096

$16.00

$18.51M

Nov 7, 2025

RA CAPITAL MANAGEMENT, L.P.

Open-market purchase

Common Stock

92,904

$16.00

$1.49M

Nov 7, 2025

RA CAPITAL MANAGEMENT, L.P.

Other

Series C Preferred Stock

12,924,620

-^{footnote F1}

Nov 7, 2025

RA CAPITAL MANAGEMENT, L.P.

Other

Series C Preferred Stock

5,889,699

-^{footnote F1}

Footnote F1 (price): Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.

Nov 5, 2025

Jeegar Pravinkumar Patel - Officer

Grant or award